This raises a number of ethical questions that we have to carefully consider, and this is why I and my colleagues have called for a global pause in any clinical application of the CRISPR technology in human embryos, to give us time to really consider all of the various implications of doing so.
Ovo postavlja brojna etička pitanja koja je potrebno pomno razmotriti, i to je razlog zašto smo kolege i ja pozvali na globalnu stanku u kliničkoj primjeni CRISPR metode na ljudskim embrijima, kako bismo uspjeli razmotriti različite implikacije za to.